Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | PARP1 | P09874 | 2/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.37 |
| ▸ | IDO1 | P14902 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | AR | P10275 | 1/20 | 0.33 |
| ▸ | IP6K1 | Q92551 | 2/20 | 0.33 |
| ▸ | IP6K3 | Q96PC2 | 1/20 | 0.33 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.33 |
| ▸ | QPCT | Q16769 | 2/20 | 0.32 |
| ▸ | DAO | P14920 | 1/20 | 0.32 |
| ▸ | PRKCI | P41743 | 1/20 | 0.31 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.31 |
| ▸ | RAD52 | P43351 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL539264 | 0.79 | PARP1 (0.41) | MAPTPARP1ALDH1A1KDM4EAPEX1 | |
| SCHEMBL2411729 | 0.79 | MAPT (0.39) | MAPTPARP1ALDH1A1KDM4EAPEX1 | |
| SCHEMBL23227827 | 0.79 | MAPT (0.47) | MAPTPARP1IDO1ALDH1A1KDM4E | |
| SCHEMBL2418293 | 0.75 | MAPT (0.36) | MAPTPARP1 | |
| SCHEMBL29171979 | 0.75 | MAPT (0.36) | MAPTPARP1 | |
| SCHEMBL19627520 | 0.75 | MAPT (0.36) | MAPTPARP1QPCT | |
| SCHEMBL12320219 | 0.75 | MAPT (0.36) | MAPTPARP1 | |
| SCHEMBL15756185 | 0.75 | MAPT (0.36) | MAPTPARP1PDPK1 | |
| SCHEMBL29285163 | 0.75 | PARP1 (0.41) | MAPTPARP1ALDH1A1KDM4EIP6K1 | |
| SCHEMBL23718064 | 0.75 | PARP1 (0.34) | MAPTPARP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026090491-A1 | ENHANCED DELIVERY OF DISEASE-TARGETED NANOBODY-SIRNA CONJUGATES | OHIO STATE INNOVATION FOUNDATION (US) | 2026-04-30 | — | — | WO | disclosed |
| US-12559766-B2 | Peanut with reduced allergen levels | INGATEYGEN LLC (US) | 2026-02-24 | — | — | US | disclosed |
| EP-3327140-B1 | CAPTURE PROBES IMMOBILIZABLE VIA L-NUCLEOTIDE TAIL | GEN PROBE INC (US) | 2025-08-06 | — | — | EP | disclosed |
| US-20250136658-A1 | ANTICONVULSANT AND NEUROPROTECTIVE AGENT | THE UAB RESEARCH FOUNDATION | 2025-05-01 | — | — | US | disclosed |
| US-12139706-B2 | Method of nonspecific target capture of nucleic acids | GEN-PROBE INCORPORATED (US) | 2024-11-12 | — | — | US | disclosed |
| CN-110167955-B | Bacterial inhibitors | 梅哈里医学院 | 2024-04-02 | — | — | CN | disclosed |
| US-11920171-B1 | Synthesis and oxidation of methane | AUBURN UNIVERSITY (US) | 2024-03-05 | — | — | US | disclosed |
| US-20230383335-A1 | CLOSED NUCLEIC ACID STRUCTURES | GEN-PROBE INCORPORATED | 2023-11-30 | — | — | US | disclosed |
| US-20230340400-A1 | MICROBIAL ESTER PRODUCTION | AUBURN UNIVERSITY (US) | 2023-10-26 | — | — | US | disclosed |
| US-11781176-B2 | Method for blocking miRNA | HUDSONALPHA INSTITUTE FOR BIOTECHNOLOGY (US) | 2023-10-10 | — | — | US | disclosed |
| EP-2635703-A1 | INTEGRATED CAPTURE AND AMPLIFICATION OF TARGET NUCLEIC ACID FOR SEQUENCING | Gen-Probe Incorporated (US) | 2013-09-11 | — | — | EP | disclosed |
| US-20130203123-A1 | CLOSED NUCLEIC ACID STRUCTURES | GEN-PROBE INCORPORATED (US) | 2013-08-08 | — | — | US | disclosed |
| WO-2013116774-A1 | ASYMMETRIC HAIRPIN TARGET CAPTURE OLIGOMERS | GEN-PROBE INCORPORATED (US) | 2013-08-08 | — | — | WO | disclosed |
| EP-2616555-A1 | CAPTURE PROBES IMMOBILIZABLE VIA L-NUCLEOTIDE TAIL | Gen-Probe Incorporated (US) | 2013-07-24 | — | — | EP | disclosed |
| WO-2013036685-A1 | CLOSED NUCLEIC ACID STRUCTURES | GEN-PROBE INCORPORATED (US) | 2013-03-14 | — | — | WO | disclosed |
| WO-2013036668-A1 | CIRCULARIZED TEMPLATES FOR SEQUENCING | GEN-PROBE INCORPORATED (US) | 2013-03-14 | — | — | WO | disclosed |
| WO-2012061412-A1 | INTEGRATED CAPTURE AND AMPLIFICATION OF TARGET NUCLEIC ACID FOR SEQUENCING | GEN-PROBE INCORPORATED (US) | 2012-05-10 | — | — | WO | disclosed |
| WO-2012037531-A1 | CAPTURE PROBES IMMOBILIZABLE VIA L-NUCLEOTIDE TAIL | GEN-PROBE INCORPORATED (US) | 2012-03-22 | — | — | WO | disclosed |
| US-20080286775-A1 | METHODS OF NONSPECIFIC TARGET CAPTURE OF NUCLEIC ACIDS | GEN-PROBE INCORPORATED (US) | 2008-11-20 | — | — | US | disclosed |
| US-20080267942-A1 | BENZAZEPIN-2(1H)-ONE DERIVATIVES | PFIZER LIMITED (GB) | 2008-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559766-B2 | Peanut with reduced allergen levels | H1-2, CPA2, RNASEH1 | MAPT 2600/4885PARP1 1119/4885GPR84 3895/4885 |
| US-20080267942-A1 | BENZAZEPIN-2(1H)-ONE DERIVATIVES | ADRB2, ADRB1, ADRA2C | MAPT 3299/4885PARP1 4275/4885GPR84 334/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.